Friday, 18 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14422
Articles
Company
Deals
MaxHealth Biotechnology Completes Series B+ Financing Round
January 29, 2025
Company
Drug
MicuRx Pharmaceuticals Gains Clinical Trial Approvals for MRX-4 in Europe
January 29, 2025
Company
Deals
F-Star Therapeutics’ Takeover by Sino Biopharmaceutical Delayed Again
January 29, 2025
Company
Deals
ST Phi Therapeutics Partners with Azenta Life Sciences to Advance Cell Therapy
January 29, 2025
Company
Drug
Beijing Wantai’s Nasal Spray COVID-19 Vaccine Approved for Emergency Use in China
January 29, 2025
Company
Deals
Everlife Biomed Raises Pre-Series A+ Funding for Immune Exemption Platform
January 29, 2025
Hospital
Hainan’s First Integrated Bladder Cancer Center Launched at Provincial Urology Meeting
January 29, 2025
Deals
Hospital
United Family Healthcare Partners with HSS for Orthopedic Collaboration
January 29, 2025
Company
Medical Device
MicroPort MedBot’s Orthopedic Surgery Robot Receives CE Certification
January 29, 2025
Company
Drug
Junshi Biosciences Files for EMA Approval of Tuoyi for Nasopharyngeal and Esophageal Cancers
January 29, 2025
Company
Deals
Akeso Biopharma Plans IPO on Shanghai’s STAR Market
January 29, 2025
Company
Novo Nordisk and ATLATL Announce Winners of EntreStar Program for Pharma Start-Ups
January 29, 2025
1
2
…
1,076
1,077
1,078
1,079
1,080
…
1,201
1,202
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?